SI9500260A - Substituted quinolin derivatives, process for their preparation and use thereof - Google Patents
Substituted quinolin derivatives, process for their preparation and use thereof Download PDFInfo
- Publication number
- SI9500260A SI9500260A SI9500260A SI9500260A SI9500260A SI 9500260 A SI9500260 A SI 9500260A SI 9500260 A SI9500260 A SI 9500260A SI 9500260 A SI9500260 A SI 9500260A SI 9500260 A SI9500260 A SI 9500260A
- Authority
- SI
- Slovenia
- Prior art keywords
- alkoxy
- chlorine
- fluorine
- optionally substituted
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- AIDS & HIV (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Cosmetics (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4428932A DE4428932A1 (de) | 1994-08-16 | 1994-08-16 | Substituierte-Chinolinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
SI9500260A true SI9500260A (en) | 1996-02-29 |
Family
ID=6525747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9500260A SI9500260A (en) | 1994-08-16 | 1995-08-16 | Substituted quinolin derivatives, process for their preparation and use thereof |
Country Status (24)
Country | Link |
---|---|
US (1) | US5798365A (da) |
EP (1) | EP0697405B1 (da) |
JP (1) | JP3860618B2 (da) |
KR (1) | KR960007567A (da) |
CN (1) | CN1123275A (da) |
AT (1) | ATE222239T1 (da) |
AU (1) | AU710238B2 (da) |
CA (1) | CA2156128A1 (da) |
CZ (1) | CZ209095A3 (da) |
DE (2) | DE4428932A1 (da) |
DK (1) | DK0697405T3 (da) |
ES (1) | ES2179857T3 (da) |
FI (1) | FI953841A (da) |
HR (1) | HRP950446A2 (da) |
HU (1) | HUT73133A (da) |
IL (1) | IL114937A0 (da) |
NO (1) | NO306296B1 (da) |
NZ (1) | NZ272730A (da) |
PL (1) | PL310030A1 (da) |
PT (1) | PT697405E (da) |
SI (1) | SI9500260A (da) |
SK (1) | SK100695A3 (da) |
TW (1) | TW407151B (da) |
ZA (1) | ZA956798B (da) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7397363B2 (en) * | 1993-06-08 | 2008-07-08 | Raymond Anthony Joao | Control and/or monitoring apparatus and method |
US6658833B2 (en) * | 2000-11-09 | 2003-12-09 | Bestrake, Llc | Collector and separator apparatus for lawn and garden |
JP2008523145A (ja) * | 2004-12-13 | 2008-07-03 | イーライ リリー アンド カンパニー | リポキシゲナーゼ阻害剤としてのスピロ誘導体 |
DE102008022221A1 (de) * | 2008-05-06 | 2009-11-12 | Universität des Saarlandes | Inhibitoren der humanen Aldosteronsynthase CYP11B2 |
CA2802492C (en) | 2010-07-02 | 2018-10-16 | Gilead Sciences, Inc. | 2-quinolinyl-acetic acid derivatives as hiv antiviral compounds |
CN103140474A (zh) | 2010-07-02 | 2013-06-05 | 吉里德科学公司 | 治疗aids的萘-2-基乙酸衍生物 |
EP3181555B1 (en) | 2011-04-21 | 2018-11-28 | Gilead Sciences, Inc. | Benzothiazole compounds and their pharmaceutical use |
WO2013103724A1 (en) | 2012-01-04 | 2013-07-11 | Gilead Sciences, Inc. | 2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids |
US9284323B2 (en) | 2012-01-04 | 2016-03-15 | Gilead Sciences, Inc. | Naphthalene acetic acid derivatives against HIV infection |
ES2668422T3 (es) | 2012-04-20 | 2018-05-18 | Gilead Sciences, Inc. | Derivados del ácido benzotiazol-6-il acético y su uso para tratar una infección por VIH |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1580492A (en) * | 1991-03-14 | 1992-10-21 | Upjohn Company, The | Reissert compounds as anti-hiv agents |
DE4142322A1 (de) * | 1991-12-20 | 1993-07-01 | Hoechst Ag | Chinoxaline, verfahren zu ihrer herstellung und ihreverwendung |
TW304945B (da) * | 1992-06-27 | 1997-05-11 | Hoechst Ag |
-
1994
- 1994-08-16 DE DE4428932A patent/DE4428932A1/de not_active Withdrawn
-
1995
- 1995-08-07 NZ NZ272730A patent/NZ272730A/en unknown
- 1995-08-10 PT PT95112585T patent/PT697405E/pt unknown
- 1995-08-10 DK DK95112585T patent/DK0697405T3/da active
- 1995-08-10 DE DE59510318T patent/DE59510318D1/de not_active Expired - Lifetime
- 1995-08-10 EP EP95112585A patent/EP0697405B1/de not_active Expired - Lifetime
- 1995-08-10 AT AT95112585T patent/ATE222239T1/de not_active IP Right Cessation
- 1995-08-10 HR HRP4428932.4A patent/HRP950446A2/hr not_active Application Discontinuation
- 1995-08-10 ES ES95112585T patent/ES2179857T3/es not_active Expired - Lifetime
- 1995-08-14 SK SK1006-95A patent/SK100695A3/sk unknown
- 1995-08-14 AU AU28531/95A patent/AU710238B2/en not_active Ceased
- 1995-08-14 FI FI953841A patent/FI953841A/fi unknown
- 1995-08-14 US US08/515,556 patent/US5798365A/en not_active Expired - Lifetime
- 1995-08-15 NO NO953204A patent/NO306296B1/no not_active IP Right Cessation
- 1995-08-15 ZA ZA956798A patent/ZA956798B/xx unknown
- 1995-08-15 HU HU9502403A patent/HUT73133A/hu unknown
- 1995-08-15 IL IL11493795A patent/IL114937A0/xx unknown
- 1995-08-15 JP JP22863995A patent/JP3860618B2/ja not_active Expired - Fee Related
- 1995-08-15 CZ CZ952090A patent/CZ209095A3/cs unknown
- 1995-08-15 CN CN95115281A patent/CN1123275A/zh active Pending
- 1995-08-15 CA CA002156128A patent/CA2156128A1/en not_active Abandoned
- 1995-08-16 PL PL95310030A patent/PL310030A1/xx unknown
- 1995-08-16 KR KR1019950025532A patent/KR960007567A/ko not_active Application Discontinuation
- 1995-08-16 SI SI9500260A patent/SI9500260A/sl unknown
- 1995-08-28 TW TW084108914A patent/TW407151B/zh active
Also Published As
Publication number | Publication date |
---|---|
ATE222239T1 (de) | 2002-08-15 |
ES2179857T3 (es) | 2003-02-01 |
PT697405E (pt) | 2002-12-31 |
AU2853195A (en) | 1996-02-29 |
HRP950446A2 (en) | 1997-08-31 |
NO953204L (no) | 1996-02-19 |
FI953841A0 (fi) | 1995-08-14 |
CZ209095A3 (en) | 1996-03-13 |
KR960007567A (ko) | 1996-03-22 |
EP0697405B1 (de) | 2002-08-14 |
PL310030A1 (en) | 1996-02-19 |
NO953204D0 (no) | 1995-08-15 |
FI953841A (fi) | 1996-02-17 |
DE4428932A1 (de) | 1996-02-22 |
HUT73133A (en) | 1996-06-28 |
NZ272730A (en) | 1998-01-26 |
US5798365A (en) | 1998-08-25 |
DK0697405T3 (da) | 2002-12-16 |
TW407151B (en) | 2000-10-01 |
JP3860618B2 (ja) | 2006-12-20 |
SK100695A3 (en) | 1996-06-05 |
HU9502403D0 (en) | 1995-10-30 |
IL114937A0 (en) | 1995-12-08 |
CN1123275A (zh) | 1996-05-29 |
DE59510318D1 (de) | 2002-09-19 |
CA2156128A1 (en) | 1996-02-17 |
JPH0859621A (ja) | 1996-03-05 |
AU710238B2 (en) | 1999-09-16 |
ZA956798B (en) | 1996-03-19 |
EP0697405A1 (de) | 1996-02-21 |
NO306296B1 (no) | 1999-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1747196B1 (en) | Substituted aryl acylthioureas and related compounds; inhibitors of viral replication | |
JP5567157B2 (ja) | N置換インデノイソキノリン及びその合成 | |
CZ9302005A3 (en) | Azaquinoxalines, process of their preparation and their use | |
JP2718595B2 (ja) | キノキサリン類およびその製法 | |
AU2004309390A1 (en) | Imidazo[4,5-c]pyridine compounds and methods of antiviral treatment | |
TW202120500A (zh) | 干擾素基因刺激蛋白(sting)激動劑化合物及用途 | |
OA13357A (en) | Azabenzofuran substituted thioureas as inhibitors of viral replication. | |
KR20180098573A (ko) | Pad4의 아자-벤즈이미다졸 억제제 | |
CS381891A3 (en) | Benzodiazepinones | |
SI9500260A (en) | Substituted quinolin derivatives, process for their preparation and use thereof | |
US6369057B1 (en) | Quinoxalines, processes for their preparation and their use | |
AU2006343604A1 (en) | 3,4-disubstituted coumarin and quinolone compounds | |
NZ328858A (en) | 7-(substituted alkylene)-oxy-flavone derivatives and medicaments | |
EP1819704B1 (en) | Pyrrolopyridine-2-carboxylic acid amide derivative useful as inhibitor of glycogen phosphorylase | |
AU670435B2 (en) | 4-iminoquinolines, processes for their preparation, and their use | |
JP4231107B2 (ja) | 抗ウイルス作用を有する置換キノリン誘導体 | |
CA2393915A1 (en) | 1,2-dihydro-1-oxo-pyrazino¬1,2-a|indole derivatives | |
CA2957566A1 (en) | Indoline sulfonamide inhibitors of dape and ndm-1 and use of the same | |
CS244698B2 (cs) | Způsob výroby v poloze 9 substituovaných derivátů 4-oxo-4H- -pyrido[1,2-a]-pyrimidinu | |
CS214797B2 (cs) | Způsob výroby nových derivátů 4-amino-2-piperidinochinazolinu |